Page 84 - JSOM Spring 2023
P. 84

17
          thermal injury from the sides of the vessel.  The tissue has   joint or metacarpophalangeal/metatarsophalangeal joints. These
          completed rewarming when it appears red or purple and is   joints have amputation rates of 60% and 100%, respectively,
                  5
                                                                                  26
          malleable.  There is no current evidence that the rewarming   without the use of iloprost.  Iloprost represents a potential key
          solution requires any antiseptic solution added to the water   in the future of cold weather injury.
              5
          bath.  Medical providers should also consult telehealth if
          available, ranging from the unit medical director to a cold   This case raises the importance of proper protective gear, im-
          weather/burn consultation. Additional efforts should be taken   mediate action when layers are compromised, frequent cold
          in the prehospital environment to optimize the patient’s hydra-  weather checks, conservative treatments, and management of
          tion status with ideally oral fluids. If the medical situation does   hemorrhagic blisters without debridement.  While extremity
          not permit, providers should initiate intravenous with warmed   cold weather injuries may be viewed as minor, they have the
          fluids if available.                               potential to rapidly degrade dexterity, short- and long-term
                                                             digit function, and combat effectiveness.
          Pain control is a crucial portion of management, including ibu-
          profen due to its effects on prostaglandin and thromboxane,   Conclusion
          with aspirin as a secondary choice.  Especially in considering
                                     10
          aspirin, medical providers should consider the platelet inhib-  The arctic environment poses a unique problem set for tactical
          itory effects for hemostasis in a combat environment versus   leaders and medical providers. Proper planning and issue and
          treatment of the cold weather injury. Ibuprofen should be ad-  wear of cold weather gear can allow the Special Operations
          ministered daily at 12mg/kg split into two doses with a maxi-  community  to mitigate  cold  weather  injury  and operational
                               10
          mum dose of 2400mg daily.  The affected extremity should be   disruption. Prevention and early recognition of cold weather
          dressed with bulky, clean, sterile dressing, with the fingers and   injuries place a high importance on the unit’s medical provider
          toes separated if possible.  If the tactical situation permits, an   to continually assess their teammates, maintaining mission
                              5
          extremity with cold weather injury should not be used or am-  capability. This article stresses the importance of Special Op-
          bulated on. However if unavoidable, case reports demonstrate   erations providers rapidly recognizing cold weather injuries
          minimal long term deleterious effects from prolonged ambula-  and taking the initial proper steps of management to prevent
          tion on cold weather injuries.  Blisters should not be debrided   more harm. The medical decision to rewarm injuries should
                                 11
          in the prehospital environment, though aloe vera application   be made in the context of potential risk of refreezing injury.
          improves outcomes in both human and animal studies with   Recognizing the severity of the injury can help medical provid-
          very minimal risk. 12,13  There are no indications for prophylac-  ers in the field make the early determination of evacuation if
          tic antibiotics, as cold weather injury is a sterile injury. How-  needed. Additionally, debriding hemorrhagic blisters can lead
          ever, in the subacute phase, edematous dermal layer incurs an   to negative patient outcomes and increased loss of tissue, while
          increased risk of gram-positive infections from the patient’s   early pain control with ibuprofen and application of aloe vera
          own flora. 14                                      can improve early healing. As arctic warfare emerges as a key
                                                             battle space, this cold weather injury pattern will become more
          Considerations for hospital care include active rewarming and   common, stressing the critical nature of these medical lessons.
          cold injury care, localized thrombolytic therapy, and vasodila-
          tors. 15,16  If able, medical providers should rewarm the affected   Disclosure
          extremity in the prehospital setting. However, if there is a   None.
          risk of refreezing, rewarming should be delayed until defini-
          tive care can be obtained. Unlike thermal or friction blisters,   Disclaimer
          blisters from cold weather injury are often managed more con-  The view(s) expressed herein are those of the author(s) and do
          servatively. The drainage of serous blisters can be considered   not reflect the official policy or position of Brooke Army Med-
          in consultation with surgical and cold weather experts. In con-  ical Center, the US Army Medical Department, United States
          trast, hemorrhagic blisters should not be unroofed.  Army Special Operations Command, the US Army Office of
                                                             the Surgeon General, the Department of the Army, the Depart-
          The use of tissue plasminogen activator (tPA) within a critical   ment of the Air Force and Department of Defense or the US
          care setting has reduced digital amputation rates, and this is   Government.
          recommended for deep tissue injury proximal to proximal in-
          terphalangeal joints. 18–21  However, clinicians must consider the   Funding
          risks versus benefits with the patient’s overall condition and   None.
          comorbidities, as systemic bleeding presents a life-threatening
          adverse effect. While not yet adopted in the US, intra-arterial   Author Contributions
          iloprost, a synthetic prostacyclin analogue originally used for   SC, NC, and RB saw the patient and generated the manuscript.
          pulmonary hypertension and Raynaud’s phenomenon, vaso-  DT provided care for the patient as well as provided addi-
          dilates and reduces platelet aggregation. This can mitigate mi-  tional comments and figures for the manuscript. BL edited the
          cro-vascular occlusion. 22,23  It is available across Europe for cold   initial first draft with multiple rounds of editing. All authors
          weather injury as well as Canada through Health Canada’s   approved the final draft.
          Special Access Program. 24,25  Based on European and Canadian
          data, the recommended dosing regimen is a six-hour intrave-  References
          nous Iloprost infusion for five days in patients with deep cold   1.  O’Donnell FL, Taubman SB. Update: Cold weather injuries, active
          weather injury that would otherwise be at risk of amputation   and reserve components, U.S. Armed Forces, July 2011–June 2016.
                                                               MSMR. 2016;23(10):12–20.
          and presenting within 72 hours of rewarming. 5,24–26  Iloprost   2.  Armed Forces Health Surveillance Division. Update: Cold weather
          infusion may reduce the need for amputation in patients with   injuries, active and reserve components, U.S. Armed Forces, July
          frostbite extending proximal to the proximal interphalangeal   2015–June 2020. MSMR. 22AD;27(11):15–24.

          82  |  JSOM   Volume 23, Edition 1 / Spring 2023
   79   80   81   82   83   84   85   86   87   88   89